Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients with Cardiomyopathy

Journal of Infectious Diseases

Volumn 212, Issue 7, 2015, Pages 1070-1081

  Schmidt Lucke, Caroline ^a,c,d   Zobel, Thomas ^a   Schrepfer, Sonja ^h   Kuhl, Uwe ^a   Wang, Dong ^h   Klingel, Karin ⁱ   Becher, Peter Moritz ^a   Fechner, Henry ^a,e   Pozzuto, Tanja ^a   Van Linthout, Sophie ^a   Lassner, Dirk ^f   Spillmann, Frank ^a   Escher, Felicitas ^a   Holinski, Sebastian ^a   Volk, Hans Dieter ^b,c   Schultheiss, Heinz Peter ^a   Tschope, Carsten ^a,c,g  

^a Department of Cardiology and Pneumology ^*  (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^d Medico Academic Consultings (MEDIACC)   (Germany)

^e UNIVERSITY OF TECHNOLOGY   (Jamaica)

^f Institut für Kardiale Diagnostik und Therapie   (Germany)

^g MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^h UNIVERSITY HEART CENTER HAMBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; endothelial progenitor cells; endothelial regeneration; reendothelialization; viruses

Indexed keywords

CASPASE 10; CASPASE 8; CD34 ANTIGEN; DEATH RECEPTOR; MESSENGER RNA; VIRUS DNA; VIRUS PROTEIN; CAPSID PROTEIN; CASP10 PROTEIN, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CARDIOMYOPATHY; CELL DAMAGE; CELL REGENERATION; CIRCULATING ANGIOGENIC CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN CELL; HUMAN PARVOVIRUS B19; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION; AGED; ANIMAL; CASE CONTROL STUDY; CELL LINE; COMPLICATION; ERYTHEMA INFECTIOSUM; ERYTHROID PRECURSOR CELL; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REGENERATION; VIROLOGY;

ADULT; AGED; ANIMALS; APOPTOSIS; CAPSID PROTEINS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CASPASE 10; CELL LINE; ENDOTHELIAL CELLS; ERYTHEMA INFECTIOSUM; ERYTHROID PRECURSOR CELLS; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; REGENERATION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84943383312     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv178     Document Type: Article

References (42)

1. Cossart YE, Cant B, Field AM, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 305:72-3.
2. Bultmann BD, Klingel K, Sotlar K, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003; 34:92-5.
3. Barzon L, Murer L, Pacenti M, et al. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury. J Infect Dis 2009; 199: 372-80.
4. Moulik M, Breinholt JP, Dreyer WJ, et al. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. J Am Coll Cardiol 2010; 56:582-92.
5. Kuhl U, Pauschinger M, Bock T, et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003; 108:945-50.
6. Bock C-T, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010; 362:1248-9.
7. Brown KE, Anderson S, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262:114-7.
8. Weigel-Kelley KA, Yoder MC, Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 2001; 75:4110-6.
9. Weigel-Kelley KA, Yoder MC, Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003; 102: 3927-33.
10. Munakata Y, Saito-Ito T, Kumura-Ishii K, et al. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005; 106:3449-56.
11. Luo W, Astell CR. A novel protein encoded by small RNAs of parvovirus B19. Virology 1993; 195:448-55.
12. Guan W, Cheng F, Yoto Y, et al. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol 2008; 82:9951-63.
13. Wong S, Zhi N, Filippone C, et al. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol 2008; 82:2470-6.
14. Pozzuto T, von Kietzell K, Bock T, et al. Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions. Virology 2011; 411:50-64.
15. von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 2007; 6:278-85.
16. Duechting A, Tschope C, Kaiser H, et al. Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells. J Virol 2008; 82:7942-52.
17. Kuhl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112:1965-70.
18. Bearzi C, Leri A, Lo Monaco F, et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci 2009; 106:15885-90.
19. Botta R, Gao E, Stassi G, et al. Heart infarct in NOD-SCID mice: Therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J 2004; 18:1392-4.
20. Madeddu P, Emanueli C, Pelosi E, et al. Transplantation of low dose CD34+Kdr+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004; 18:1737-9.
21. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111:2981-7.
22. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999-1007.
23. Cheng S, Cohen KS, Shaw SY, et al. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation 2010; 122:1176-82.
24. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103:2885-90.
25. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104:2752-60.
26. Yoder MC, Mead LE, Prater D, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109:1801-9.
27. Meneveau N, Deschaseaux F, Séronde M-F, et al. Presence of endothelial colony-forming cells is associated with reduced microvascular obstruction limiting infarct size and left ventricular remodelling in patients with acute myocardial infarction. Basic Res Cardiol 2011; 106: 1397-410.
28. Schmidt-Lucke C, Spillmann F, Bock T, et al. Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus B19V infection. J Infect Dis 2010; 201:936-45.
29. Yoder MC. Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl) 2013; 91: 285-95.
30. Asahara T, Kawamoto A, Masuda H. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 2011; 29: 1650-5.
31. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012; 110:624-37.
32. Shimomura S, Komatsu N, Frickhofen N, Anderson S, Kajigaya S, Young N. First continuous propagation of B19 parvovirus in a cell line. Blood 1992; 79:18-24.
33. Sorrentino SA, Besler C, Rohrer L, et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010; 121:110-22.
34. Bonsch C, Kempf C, Ros C. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol 2008; 82:11784-91.
35. Roy S, Tripathy M, Mathur N, Jain A, Mukhopadhyay A. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency. Eur J Haematol 2012; 88:396-405.
36. Ishikawa Y, Ito T. Kinetics of hemopoietic stem cells in a hypoxic culture. Eur J Haematol 1988; 40:126-9.
37. Pillet S, Le Guyader N, Hofer T, et al. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 2004; 327:1-7.
38. Quattrocchi S, Ruprecht N, Bonsch C, et al. Characterization of the early steps of human parvovirus B19 infection. J Virol 2012; 86:9274-84.
39. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012; 2:a006692.
40. Lancrin C, Sroczynska P, Stephenson C, Allen T, Kouskoff V, Lacaud G. The haemangioblast generates haematopoietic cells through a haemogenic endothelium stage. Nature 2009; 457:892-5.
41. Rong Q, Huang J, Su E, et al. Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells. Virol J 2007; 4:36.
42. Chen AY, Zhang EY, Guan W, et al. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 2010; 115:1070-80.